IAV H5N1 HA (aa 55-271) Specific Neutra™ Antibody (V3S-1023-FY73), Human IgG (CAT#: V3S-1023-FY73)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a IAV H5N1 HA broadly neutralizing antibody. The monoclonal antibody bound to the head group have binding and neutralizing activities at 2.30-Å resolution. The antibody can inhibit viral attachment and the post-attachment fusion step.
Clonality Monoclonal
Host Species Human
Target Species Influenzavirus A Subtype H5N1
Epitope AA 55-271 (A/Anhui/1/2005 HA)
Neutralization Mechanism AVFluIgG01 inhibits HA-mediated membrane fusion in a dose-dependent manner and prevents the acquisition of pH-induced protease sensitivity.
IC50 0.012 ± 0.016 ug/mL
Isotype Human IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application Neut

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target IAV H5N1 HA
Alternative Name Influenza A virus Hemagglutinin; Influenza A virus; Hemagglutinin; HA; IAV; H5; H5N1; IAV H5N1
Research Area Microbiology
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry